Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
PureTech Share News (PRTC)
PRTC Share
Price
PRTC Share
News
PRTC Share
Chat
PRTC Share
Trades215
PRTC
Live RNS
PRTC Share
Charts
PRTC Level 2
Console
PRTC Live
Share Price
PRTC Broker
Ratings
PRTC Directors
Deals
PRTC Financial
Diary
PRTC
Fundamentals
PRTC Short
Positions2
PRTC
Media
PRTC Company
Research
PRTC Company
Timeline2
Share Price Information for PureTech (PRTC)
Last checked at -
Last checked at 
Intraday PureTech Share Chart
IN BRIEF: PureTech To Begin Nasdaq Trading On Monday
PureTech Health PLC - Boston-based biotherapeutics company - To begin trading of American depositary shares on Nasdaq on Monday. Each ADS represents 10 PureTech shares. Also notes that founded entity Gelesis presented data showing its hydrogel product reverses intestine damaged induced by diets high in fat.
Current stock price: 277.51 pence
Year-to-date change: down 12%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Latest PRTC News
- DIRECTOR DEALINGS: PureTech Health directors buy GBP176,000 in shares
2 days ago - PureTech launches Celea Therapeutics with USD180 million financing
2 Jul 2026 - PureTech-founded Seaport reports positive GlyphAgo phase 1 data
9 Jun 2026 - PureTech Health notes pricing of Seaport Therapeutics for Nasdaq IPO
1 May 2026 - EARNINGS AND TRADING: Naked Wines eyes top-end earnings but sales flag
29 Apr 2026 - LONDON BRIEFING: AstraZeneca, Lloyds, GSK post first-quarter growth
29 Apr 2026 - UK earnings, trading statements calendar - next 7 days
22 Apr 2026 - PureTech Health's Seaport files for possible Nasdaq listing
13 Apr 2026
Related News
DIRECTOR DEALINGS: PureTech Health directors buy GBP176,000 in shares
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separate...
PureTech launches Celea Therapeutics with USD180 million financing
(Alliance News) - PureTech Health PLC on Thursday said its founded entity Celea Therapeutics Inc has completed a USD180 million financing, which will ...
PureTech-founded Seaport reports positive GlyphAgo phase 1 data
(Alliance News) - PureTech Health PLC on Tuesday highlighted positive phase 1 data from Seaport Therapeutics Inc for GlyphAgo, supporting plans to adv...
PureTech News
DIRECTOR DEALINGS: PureTech Health directors buy GBP176,000 in shares
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separate...
PureTech launches Celea Therapeutics with USD180 million financing
(Alliance News) - PureTech Health PLC on Thursday said its founded entity Celea Therapeutics Inc has completed a USD180 million financing, which will ...
PureTech-founded Seaport reports positive GlyphAgo phase 1 data
(Alliance News) - PureTech Health PLC on Tuesday highlighted positive phase 1 data from Seaport Therapeutics Inc for GlyphAgo, supporting plans to adv...
PureTech Health notes pricing of Seaport Therapeutics for Nasdaq IPO
(Alliance News) - PureTech Health PLC on Friday noted the pricing of its founded entity Seaport Therapeutics Inc for its planned initial public offeri...
EARNINGS AND TRADING: Naked Wines eyes top-end earnings but sales flag
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...
LONDON BRIEFING: AstraZeneca, Lloyds, GSK post first-quarter growth
(Alliance News) - AstraZeneca, Lloyds Banking Group and GSK report higher earnings in the first quarter.
PureTech Health's Seaport files for possible Nasdaq listing
(Alliance News) - PureTech Health PLC on Monday said that Seaport Therapeutics Inc, founded by PureTech, had filed for an initial public offering on N...
Follow the stocks
